Rakovina Therapeutics Inc. (RKVTF)
OTCMKTS · Delayed Price · Currency is USD
0.1355
+0.0288 (26.95%)
At close: Feb 11, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of $2.8 million as of February 12, 2026. Its market cap has decreased by -87.54% in one year.
Market Cap
2.80M
Enterprise Value
4.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 11.84M to 2.80M, a decrease of -76.33%. That is a compound annual growth rate of -25.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.80M | 81.61% |
| Dec 31, 2025 | 1.54M | -91.69% |
| Dec 31, 2024 | 18.55M | 311.27% |
| Dec 29, 2023 | 4.51M | -51.33% |
| Dec 29, 2022 | 9.27M | -23.63% |
| Dec 31, 2021 | 12.14M | 2.54% |
| Apr 1, 2021 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 3.99M |
| Clearside Biomedical | 3.57M |
| Enzolytics | 2.90M |
| Mosaic ImmunoEngineering | 2.27M |
| ProtoKinetix | 2.12M |
| Neon Bloom | 1.85M |
| Carisma Therapeutics | 1.68M |
| Agentix | 1.68M |